PAP

Persistent Asset Partners Portfolio holdings

AUM $258M
1-Year Est. Return 159.18%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+159.18%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$208M
AUM Growth
+$70M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
392
New
Increased
Reduced
Closed

Top Buys

1 +$8.43M
2 +$5.15M
3 +$4.26M
4
SNDK
Sandisk
SNDK
+$3.61M
5
JNJ icon
Johnson & Johnson
JNJ
+$3.5M

Top Sells

1 +$4.82M
2 +$3.15M
3 +$2.87M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.84M
5
LH icon
Labcorp
LH
+$2.58M

Sector Composition

1 Healthcare 56.04%
2 Technology 14.52%
3 Financials 12.06%
4 Communication Services 4.8%
5 Energy 4.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LBRX
251
LB Pharmaceuticals
LBRX
$927M
$90.8K 0.04%
+4,080
XGN icon
252
Exagen
XGN
$83.8M
$80.4K 0.04%
+13,230
IBIO icon
253
iBio
IBIO
$56M
$76.4K 0.04%
+39,585
CNTB
254
Connect Biopharma Holdings
CNTB
$138M
$75.5K 0.04%
+26,774
FULC icon
255
Fulcrum Therapeutics
FULC
$483M
$74.8K 0.04%
+6,615
SABS icon
256
SAB Biotherapeutics
SABS
$278M
$74K 0.04%
+19,790
SYRE icon
257
Spyre Therapeutics
SYRE
$6.63B
$73.6K 0.04%
+2,246
ACRS icon
258
Aclaris Therapeutics
ACRS
$711M
$67K 0.03%
+22,259
TARA icon
259
Protara Therapeutics
TARA
$286M
$57.2K 0.03%
+10,733
AARD
260
Aardvark Therapeutics
AARD
$144M
$55.5K 0.03%
+4,231
CRBP icon
261
Corbus Pharmaceuticals
CRBP
$215M
$53.6K 0.03%
+6,587
NEUP
262
Neuphoria Therapeutics
NEUP
$26.8M
$52K 0.03%
13,403
+8,495
PLRX icon
263
Pliant Therapeutics
PLRX
$72.4M
$47.4K 0.02%
+38,831
CDXS icon
264
Codexis
CDXS
$227M
$45.3K 0.02%
+27,813
TLPH icon
265
Talphera
TLPH
$46.8M
$41.8K 0.02%
+36,630
YSG
266
Yatsen Holding
YSG
$257M
$40.2K 0.02%
10,332
+5,332
CMPS
267
Compass Pathways
CMPS
$1.48B
$37.8K 0.02%
+5,483
CLYM
268
Climb Bio
CLYM
$653M
$36.9K 0.02%
9,228
-18,993
XBIT icon
269
XBiotech
XBIT
$76.2M
$32.4K 0.02%
+13,565
PRTC
270
PureTech Health
PRTC
$426M
$29.4K 0.01%
1,759
+74
INBX icon
271
Inhibrx
INBX
$1.72B
$27.3K 0.01%
+346
MELI icon
272
Mercado Libre
MELI
$79.2B
$20.1K 0.01%
+10
VTGN icon
273
VistaGen Therapeutics
VTGN
$26M
$17.6K 0.01%
26,612
-48,707
EDSA icon
274
Edesa Biotech
EDSA
$135M
$17.5K 0.01%
+12,319
PNTG icon
275
Pennant Group
PNTG
$1.24B
$10K ﹤0.01%
356
-76,055